The statistics are staggering - roughly 9% of the global population suffers from kidney disease, and developing novel therapies for kidney diseases has historically been challenging for a number of reasons. Chinook is revolutionizing kidney disease treatment by leveraging our increased understanding of the biological pathways and the acceptance of surrogate markers as registration endpoints by regulatory agencies. I feel very fortunate to contribute to the innovative work Chinook is doing, and am inspired daily by the bright, thoughtful and passionate individuals who are dedicated to improving the lives of patients with kidney diseases.

Noopur Liffick, VP, Investor Relations & Corporate Communications

Chinook is such a fun and inspiring place to work. The environment is nurturing and collaborative across all departments – every voice and idea matters. I am very grateful to be working with such amazing people with the common goal in helping kidney patients have a better future.

Leanne Luu, Administrative Assistant I

I love working with a team comprised of such passionate and motivated individuals. We all share the same vision of finding treatments for kidney disease. This shared vision creates a collaborate environment where everyone supports each other.

Jerlyn Tolentino, Associate Director, Clinical Trial Management